Question.3552 - Instructions: Antitrust Case (February 2022) The Department of Justice has filed a civil lawsuit to stop the $13 billion merger between UnitedHealth Group and Change Healthcare. Why would the Justice Department be concerned about this merger? What are the considerations in considering whether a merger is anticompetitive, and perhaps contrary to the public interest. What are other examples of mergers in healthcare where antitrust issues have been considered or should be considered? Resources Antitrust Laws United Group Acquisition Healthcare Healthcare Finance QuestionsBe sure to support your arguments. What type of mergers should be prevented in healthcare? What are the benefits of mergers and consolidation, for the companies? for patients? Are there sectors of healthcare that are closer to perfect competition than others, i.e., is there a spectrum of competitiveness?
Answer Below:
Type xx mergers xx be xxxxxxxxx in xxxxxxxxxx In xxx Senate xxxxxxxxx FTC xx Federal xxxxx Commission xxxxx the xxxxxxxxxxx of xxx Clayton xxx under xxxxxxxx and xxxxxxxxxx and xxxxxxxxxxx unlawful xxxxx contracts xxxxxxxxx mergers xxx acquisitions xxx interlocking xxxxxxxxxxxx Federal xxxxx Commission xxxxx on xxxx act xx February xxx US xxxxxxxxxx of xxxxxxx filed x lawsuit xx block xxx billion xxxxxxx UnitedHealth xxxxx and xxxxxx Healthcare xxxx merger xxxxxx raised xxxxxxxxx issues xxx to xxx risk xx data xxxxxxxx reduced xxxxxxxxxxx and xxxxxx dominance xxx DOJ xxx expressed xxxx UnitedHealth xxxx owning xxxxxxx US xxxxxx insurer xxxxxxxxxxxxxxxx gaining xxx much xxxxxxx over xxxxxxxx healthcare xxxx and xxxx merger xxxxx potentially xxxx to xxxxxxx competition xxxx Benefits xx mergers xxx consolidation xxx companies xxx patients xx order xx consider xxxxxxxxx mergers xxx antitrust xxxxxxxx it xx crucial xx evaluate xxxx if xxx merger xx anticompetitive xx not xxxxx is xxxxxxxx by xxx FTC xxx the xxxxxxx Act xx the xxxxxxx U x C xxxxxxxx and xxxx outlawed xx the xxxxxxx Act xxxxxxxxx mergers xxx consolidation xxxxx benefit xxxxxxxxx by xxxxxxxx costs xx combining xxxxxxxxx and xxxxxxxxxxx redundancies xxxxx from xxxx increasing xxxxxx share xxx enhanced xxxxxxxxxx may xxxx to xxxxxxxxxxx benefits xxx companies xxxxxxx anticompetitive xxxxxxx On xxx other xxxx patients xxxxx even xxxxxxx from xxxxxxxxxx care xxx cost-saving xxxxxxx in xxxxx costs xxx patients xxxx Spectrum xx competitiveness x perfect xxxxxxxxxxx means xxxx all xxx firms xxxx a xxxxxxxxxx product xxx no xxxxxx firm xxx influence xxx market xxxxx of xxx good xx service xxxxxxx the xxxxxx determines xxx price xxxxx on xxx supply xxx demand xx nexus xxxx this xxxxxxx competition xx healthcare xxxxx be xxxxxxx in xxxxxxx such xx pharmaceuticals xxxxxxxxx and xxxxxxx care xxxx reflect xxxxxxxxxx products xxx concentrated xxxxxxxx in xxx market xxxx ReferencesFederal xxxxx Commission xxxxx Guide xx antitrust xxxx Retrieved xxxxxxxxx from xxxxx www xxx gov xxxxxxxxxxxxxxx competition-guidance xxxxxxxxxxxxxxxxxxxxxx Department xx Justice xxxxxxxx Justice xxxxxxxxxx sues xx block xxxxxxxxxxxx Group xxxxx s xxxxxxxxxxx of xxxxxx Healthcare xxxxxxxxx September xxxx https xxx justice xxx opa xx justice-department-sues-block-unitedhealth-group-s-acquisition-change-healthcareHealthcare xxxxxxx News xxx releases xxxxx Direct-Care xxxxxxxxx state xxxx Center xxxxxxxxx September xxxx https xxx healthcarefinancenews xxx news xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx nbspMore Articles From Health
.ico)
.ico)
.ico)
.ico)
